期刊文献+

复发性胃肠间质瘤再次手术 被引量:5

Reoperation for recurrent gastrointestinal stromal tumors
原文传递
导出
摘要 外科手术目前仍是胃肠间质瘤(GIST)病人获得根治的最佳手段,但术后复发转移是GIST病人治疗失败及死亡的主要原因。对于复发性GIST,外科治疗并不是最佳选择,应联合酪氨酸激酶抑制剂甲磺酸伊马替尼,结合病人的不同情况,个体化制定综合治疗方案,以提高病人总生存期。 Surgical resection is still the primary curative treatment for gastrointestinal stromal tumor(GIST) patients. However, postoperative recurrence and metastasis of tumors are the major causes of treatment failure and patients death. Surgery is not the best choice for recurrent GIST. It is considerable to combine surgical and molecular therapy to increase the overall survival of GIST patients.
作者 蔡建强
出处 《中国实用外科杂志》 CSCD 北大核心 2010年第4期275-277,共3页 Chinese Journal of Practical Surgery
关键词 胃肠间质瘤 甲磺酸伊马替尼 gastrointestinal stromal tumor (GIST) imatinib mesylate
  • 相关文献

参考文献9

  • 1杜春燕,师英强,傅红,赵广法,周烨,蔡国响.胃肠道间质瘤103例预后分析[J].中国实用外科杂志,2007,27(4):297-299. 被引量:49
  • 2Jason S, Goht MD, Ronald P, et al. Combined surgical and molecular therapy:the, gastrointestinal stromal tumor model [J]. Ann Surg, 2006,244(2): 176-184.
  • 3Fletcher CD, Bemml J J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach [J]. Hum Pathol, 2002, 33(5) : 459-465.
  • 4Langer C, Gunawan B, Sehuler P, et al. Prognostic faclors influencing surgical management and outcome of gastrointestinal stromal tumours[J ]. Br J Surg, 2003,90(3):332-339.
  • 5何裕隆.胃肠道间质瘤的外科治疗进展[J].中国实用外科杂志,2006,26(8):629-630. 被引量:21
  • 6Dematteo RP, Ballman KV, Antoncscu CR, et al. Adjuvant imatinib mesylate after resection of localized, primary, gastrointestinal slromal tumor: a randomised, double-blind, placebo-controlled trial[ J ]. Lancet, 2009,373(9669): 1097-1104.
  • 7Crosby JA Cattnn CN, Davis A, et al. Malignant gastrointestinal stromal lumors of the small intestine: a review of 50 cases from a prospective database[J]. Ann Surg Oncol, 2001,8(1):50-59.
  • 8Chandrajit P, Raut Stanley, Ashley W. How I do it: surgical management of gastrointestinal stromal tumors [J]. J Gastrointest Surg, 2008, 12(9):1592-1599.
  • 9Mudan SS, Conlon KC, Woodruff JM, et al. Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection [ J ]. Cancer, 2000, 88(1):66-74.

二级参考文献21

  • 1万德森.胃肠道间质瘤的治疗——外科医生的观点[J].中国现代手术学杂志,2005,9(3):161-163. 被引量:15
  • 2Hirota S,Isozaki K,Moriyama Y,et al.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors[J].Science,1998,279(5350):577-80.
  • 3DeMatteo R,Lewis JJ,LeungD,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival[J].Ann Surg,2000,231(1):51-58.
  • 4Fletcher CD,Berman JJ,Corless C,et al.Diagnosis of gastrointestinal stromal tumors:a consensus approach[J].Hum Pathol,2002,33(5):459-465.
  • 5Rossi CR,Mocellin S,Mencarelli R,et al.Gastrointestinal stromal tumors:from a surgical to a molecular approach[J].Int J Cancer,2003,107(2):171.
  • 6Bryan C,Ronald P,DeMatteo MD,et al.Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum:A clinical comparison[J].Ann Surg Oncol,2001,8(4):290-299.
  • 7Lehnert T.Gastrointestinal sarcoma (GIST)-a review of surgical management[J].Annales Chirurgiae Gynaecologiae,1998,87(4):297.
  • 8Iwahashi M,Takifuji K,Ojima T,et al.Surgical management of small gastrointestinal stromal tumors of the stomach[J].World J Surg,2006,30(1):28-35.
  • 9Chien-Yuh Yeh,Hong-Hwa Chen,Reiping Tang.Surgical outcome after curative resection of rectal leiomyosarcoma[J].Dis Colo Rect,2000,43(11),1517-1521.
  • 10Miettinen M,Furlong M,Sarlomo,et al.Gastrointestinal stromal tumors,Intramural leiomyomas,and leiomyosarcomas in the rectum and anus:a clinicopathologic immunohistochemical and molecular genetic study of 144 cases[J].Am J Surg Patholy,2001,25(9):1121-1133.

共引文献67

同被引文献39

  • 1Miettinen M,Sarlomo-Rikala M,Lasota J. Gastrointestinal Strmal tumors:recent advances in understanding of their biology[J].Human Pathology,2009,(10):1213-1220.
  • 2Fletcher CD,Bemoan JI,Corless C. Diagnosis of gastrointestinal stromal tumors A consensus approach[J].Human Pathology,2002.495-446.
  • 3Agaimy A,TerraccianoLM,Dirnhofer S. V600E BRAF mutations are alternative early molecular events in a subset of KIT / PDG FRA wild-type gastrointestinal stromal tumours[J].Journal of Clinical Pathology,2009.613-616.
  • 4Blay J Y,Reichardt P. Advanced gastrointestinal stromal tumor in Europe,a review of updated treatment recommendations[J].Expert Review of Anticancer Therapy,2009.831-838.
  • 5DematteoRP,Ballman KV,Antoncscu CR. Adjuvant imatinib mesylate after resection of localized,primary,gastrointestial slromal tumor:a randomised,double-blind,placebocontrolldtrial[J].The Lancet,2009,(9669):1097-1104.
  • 6Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathologyand prognosis at different sites[j]. Semin Diagn Pathol,2006,23(2):70-83.
  • 7DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointes-tinal stromal tumors: Recurrence patterns and prognostic factorsfor survival[j]. Ann Surg,2000,231(1):51 -58.
  • 8Joensuu H. Risk stratification of patients diagnosed with gastro-intestinal stromal tumor [j]. Hum Pathol, 2008, 39(10):1411-1419.
  • 9DeMatteo RP, Ballman KV, Antonescu CR, et al. Adjuvant ima-tinib mesylate after resection of localised, primary gastrointesti-nal stromal tumour: a randomised, double-blind, plac,eho-ocm-trolled trial[j]. Lancet,2009,373 (9669):1097-1104.
  • 10Joensuu H, Eriksson M, Sundby Hall K, et al. One vs three yearsof adjuvant imatinib for operable gastrointestinal stromal tumor:a randomized trial [j]. JAMA, 2012,307(12):1265-1272.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部